Gain Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:GANX) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities -6.08 M-3.45 M-3.82 M-5.1 M-4.93 M -17.3 M Cash from investing activities -1-43.45 K3.02 M2 M-1 — Cash from financing activities 808.68 K2.31 M2.4 M2.47 M7.03 M 14.21 M Free cash flow -6.08 M-3.45 M-3.82 M-5.1 M-4.93 M -17.3 M

뉴스

파킨슨병 바이오마커 81% 감소 보고 - Gain Therapeutics

Gain Therapeutics reports 81% reduction in Parkinson’s biomarker

Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - BioAtla (NASDAQ:BCAB), ChowChow Cloud Internatio (AMEX:CHOW)

Gain Therapeutics (GANX) Upgraded to Buy: Here's Why

Roth/MKM, Gain Therapeutics 목표 주가 17,000원으로 상향

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14%

Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?

Here's Why Gain Therapeutics, Inc. (GANX) is a Great Momentum Stock to Buy

게인 테라퓨틱스, 임상 데이터 발표 앞두고 ’매수’ 등급 유지

H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock ahead of trial data

게인 테라퓨틱스, 3550만 달러 규모의 주식 공모 추가 설명서 제출

Gain Therapeutics files prospectus supplement for $35.5 million stock offering